Findings from a Mini-Sentinel Medical Product Assessment: Influenza Vaccines and Risk of Febrile Seizures

Project Title Findings from a Mini-Sentinel Medical Product Assessment: Influenza Vaccines and Risk of Febrile Seizures
Date
Monday, July 21, 2014
Medical Product
TIV
pneumococcal conjugate (PCV13)
DTaP vaccine
DTaP combination vaccine
Health Outcome
Febrile seizures
Population / Cohort
Children 6-59 months
Time Period
July 2010-June 2011
Host

Gregory W. Daniel, PhD, MPH, Managing Director for Evidence Development & Innovation, Engelberg Center for Health Care Reform, Brookings Institution, Washington DC

Data Sources
Mini-Sentinel Distributed Database
Location
Presenters

Michael Nguyen, MD, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, MD; Alison Kawai, ScD, SM, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute

Related Assessments